checkAd
    Catalyst Pharmaceuticals Aktie
    15,120
     
    USD
    +2,65 %
    +0,390 USD
    Letzter Kurs 02:00:00 Nasdaq
    15,120
     
    USD
    1.000 STK
    Geldkurs 24.04.24
    15,130
     
    USD
    1.800 STK
    Briefkurs 24.04.24
    ISIN: US14888U1016 · WKN: A0LCUL · SYM: CPRX · USA

    Neueste Nachrichten

    Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
    22.04.24 · globenewswire · Catalyst Pharmaceuticals
    Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
    28.03.24 · globenewswire · Catalyst Pharmaceuticals
    Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
    27.03.24 · globenewswire · Catalyst Pharmaceuticals
    Catalyst Pharmaceuticals Announces AGAMREE Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
    13.03.24 · globenewswire · Catalyst Pharmaceuticals
    Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference
    05.03.24 · globenewswire · Catalyst Pharmaceuticals
    Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
    29.02.24 · globenewswire · Catalyst Pharmaceuticals
    Fokus Aktien mit extremen Handelsvolumen am Dienstag, den 27.02.2024
    27.02.24 · wO Chartvergleich · Danieli & C.Officine Meccaniche
    Catalyst Pharmaceuticals to Present at MDA Clinical & Scientific Conference Details of Registry for Study of Long-Term Safety and Quality of Life in Duchenne Muscular Dystrophy Patients Treated with AGAMREE
    27.02.24 · globenewswire · Catalyst Pharmaceuticals
    Catalyst Pharmaceuticals Announces Publication of Santhera Pharmaceutical’s VISION-DMD Vamorolone (AGAMREE) Study Results in the Peer-Reviewed Journal Neurology
    21.02.24 · globenewswire · Catalyst Pharmaceuticals
    Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
    14.02.24 · globenewswire · Catalyst Pharmaceuticals
    Fokus Aktien mit extremen Handelsvolumen am Montag, den 22.01.2024
    22.01.24 · wO Chartvergleich · Archer Daniels Midland Company
    Catalyst Pharmaceuticals, Inc. Announces Closing of Public Offering
    09.01.24 · globenewswire · Catalyst Pharmaceuticals